SIE

207.8

-2.21%↓

AIR.FR

162.54

-2.62%↓

ENR.DE

147.3

-0.91%↓

RHM

1,451

-4.76%↓

HO

236.4

-3%↓

SIE

207.8

-2.21%↓

AIR.FR

162.54

-2.62%↓

ENR.DE

147.3

-0.91%↓

RHM

1,451

-4.76%↓

HO

236.4

-3%↓

SIE

207.8

-2.21%↓

AIR.FR

162.54

-2.62%↓

ENR.DE

147.3

-0.91%↓

RHM

1,451

-4.76%↓

HO

236.4

-3%↓

SIE

207.8

-2.21%↓

AIR.FR

162.54

-2.62%↓

ENR.DE

147.3

-0.91%↓

RHM

1,451

-4.76%↓

HO

236.4

-3%↓

SIE

207.8

-2.21%↓

AIR.FR

162.54

-2.62%↓

ENR.DE

147.3

-0.91%↓

RHM

1,451

-4.76%↓

HO

236.4

-3%↓

Search

Teleperformance SE

Open

SectorIndustrials

48.99 -1.67

Overview

Share price change

24h

Current

Min

48.05

Max

50.7

Key metrics

By Trading Economics

Income

-1M

248M

Sales

-23M

5.1B

P/E

Sector Avg

6.064

61.065

Dividend yield

8.78

Profit margin

4.869

Employees

446,716

EBITDA

99M

988M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+56.56% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

8.78%

2.23%

Market Stats

By TradingEconomics

Market Cap

42M

3B

Previous open

50.66

Previous close

48.99

News Sentiment

By Acuity

80%

20%

387 / 406 Ranking in Industrials

Technical Score

By Trading Central

Confidence

Bullish Evidence

Teleperformance SE Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

23 mar 2026, 23:47 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mar 2026, 22:55 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mar 2026, 21:51 UTC

Acquisitions, Mergers, Takeovers

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mar 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23 mar 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mar 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mar 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mar 2026, 22:42 UTC

Market Talk
Major News Events

Global Equities Roundup: Market Talk

23 mar 2026, 22:42 UTC

Market Talk
Major News Events

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mar 2026, 22:40 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mar 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mar 2026, 22:22 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mar 2026, 22:21 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mar 2026, 22:21 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mar 2026, 22:20 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mar 2026, 22:20 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mar 2026, 22:19 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mar 2026, 22:19 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mar 2026, 22:18 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mar 2026, 22:15 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mar 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mar 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23 mar 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mar 2026, 21:10 UTC

Major News Events

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mar 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23 mar 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23 mar 2026, 20:50 UTC

Market Talk
Earnings
Major News Events

Basic Materials Roundup: Market Talk

Peer Comparison

Price change

Teleperformance SE Forecast

Price Target

By TipRanks

56.56% upside

12 Months Forecast

Average 80 EUR  56.56%

High 115 EUR

Low 50 EUR

Based on 6 Wall Street analysts offering 12 month price targets forTeleperformance SE - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

6 ratings

3

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

91.28 / 94.3Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Strong Bearish Evidence

Sentiment

By Acuity

387 / 406 Ranking in Industrials

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Teleperformance SE

Teleperformance SE, together with its subsidiaries, engages in the customers consultancy services in France and internationally. The company operates in two segments, Core Services and Digital Integrated Business Services, and Specialized Services. The company offers customer relationship operations, technical support, technical assistance and customer acquisition services, management of business processes, back office and digital platform services, consulting, data analysis services, on-line interpretation, visa application management, health management services, and accounts receivable credit management services, and recruitment process outsource services. It also provides digital CX, trust and safety, artificial intelligence, video CX, metaverse, CX management, advanced analytics, business transformation consulting, technology as a service, collection service, interpretation and translation, and healthcare support services. The company serves automotive, energy and utilities, insurance, government, technology, travel and hospitality, and banking and financial services, as well as healthcare, media, retail and e-commerce, cargo, telecom, and video games industries. Teleperformance SE was incorporated in 1910 and is headquartered in Paris, France.
help-icon Live chat